Literature DB >> 12065932

IMAGe association: additional clinical features and evidence for recessive autosomal inheritance.

Anne Lienhardt1, Jean-C Mas, Gabriel Kalifa, Jean-Louis Chaussain, Maïthé Tauber.   

Abstract

Congenital adrenal hypoplasia (CAH) normally occurs in the neonatal period, with patients presenting with more or less severe salt-wasting syndrome. X-linked CAH has been associated with mutations in the DAX-1 gene, and boys have also been shown to have hypogonadotrophic hypogonadism. Recently, in three unrelated boys, CAH was associated with intrauterine growth retardation (IUGR), metaphyseal dysplasia and genital abnormalities, defining a new association called IMAGe. We now report four additional patients with this association, including the first living female. The four patients belong to two unrelated families (one brother and one sister from each family). These patients have the main clinical characteristics of IMAGe association: IUGR, facial dysmorphy (frontal bossing, broad nasal bridge, low-set ears), short limbs due to metaphyseal dysplasia, and adrenal insufficiency. As these patients are older than the initial three patients, we can also describe additional features: short adult height, normal puberty in boys as well as in the living girl. The boys have hypospadias associated with micropenis. The living girl came to clinical attention at the age of 5 years as a result of a familial survey, and careful questioning revealed that she had been suffering from mild adrenal insufficiency since early childhood. At least one boy has congenital hypotonia due to muscular dystrophy. In conclusion, these four new cases display familial transmission, strongly suggesting Mendelian autosomal recessive inheritance. Adrenal insufficiency may be mild. Hypotonia, described in all the patients, might be related to paucisymptomatic muscular dystrophy, as this condition is clearly heterogeneous varying with regard to severity, associated manifestations and outcome. If this symptom is part of the syndrome, which we cannot assume, it could help to localize the candidate gene. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065932     DOI: 10.1159/000058105

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

1.  A case of a Korean newborn with IMAGe association presenting with hyperpigmented skin at birth.

Authors:  Jung Min Ko; Jung Hyun Lee; Gu-Hwan Kim; Ai-Rhan Kim; Han-Wook Yoo
Journal:  Eur J Pediatr       Date:  2006-11-22       Impact factor: 3.183

2.  Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2.

Authors:  Jeffry M Cesario; Andre Landin Malt; Lindsay J Deacon; Magnus Sandberg; Daniel Vogt; Zuojian Tang; Yangu Zhao; Stuart Brown; John L Rubenstein; Juhee Jeong
Journal:  Hum Mol Genet       Date:  2015-06-12       Impact factor: 6.150

3.  Anesthetic and dental management of a child with IMAGe syndrome.

Authors:  Rochelle G Lindemeyer; Stephanie E Rashewsky; Phillip J Louie; Laura Schleelein
Journal:  Anesth Prog       Date:  2014

4.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

5.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome.

Authors:  Valerie A Arboleda; Hane Lee; Rahul Parnaik; Alice Fleming; Abhik Banerjee; Bruno Ferraz-de-Souza; Emmanuèle C Délot; Imilce A Rodriguez-Fernandez; Debora Braslavsky; Ignacio Bergadá; Esteban C Dell'Angelica; Stanley F Nelson; Julian A Martinez-Agosto; John C Achermann; Eric Vilain
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

6.  Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome.

Authors:  Naoki Hamajima; Yoshikazu Johmura; Satoshi Suzuki; Makoto Nakanishi; Shinji Saitoh
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.